Latest Breaking News On - Muscarinic agonist - Page 1 : vimarsana.com

Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a low incidence rate of extrapyramidal symptoms was reported over.

United statesAlyssa johnsenBristol myers squibbExchange commissionAmerican society of clinical psychopharmacologyUs food drug administrationAbnormal involuntary movement scaleClinical psychopharmacologyAnnual meetingBristol myersDrug administrationLong term riskExtrapyramidal symptomsMuscarinic agonistSimpson angus scaleBarnes akathisia rating scale